Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $129.7M
Liabilities Breakdown FY2012
Total Liabilities: $20.3M
Asset Breakdown
Total Assets: $129.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $46.5M | 35.9% |
| Accounts Receivable | $2.8M | 2.2% |
| Inventory | $9.6M | 7.4% |
| Property, Plant & Equipment | $14.3M | 11.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $56.4M | 43.5% |
Liabilities Breakdown
Total Liabilities: $20.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 14.7% |
| Long-Term Debt | $2.6M | 12.9% |
| Other Liabilities | $14.7M | 72.4% |